{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System Tobramycin (0.5-16 \u03bcg/mL)",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent tobramycin (0.5-16 \u03bcg/mL)"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K052250",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "September 30, 2005",
    "Summary Letter Received Date": "August 18, 2005",
    "Submission Date": "August 16, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tobramycin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates",
        "Gram-positive bacteria",
        "Gram-negative aerobic and facultative anaerobic bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator detection",
        "Turbidity measurement"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System Tobramycin antimicrobial susceptibility testing for Gram-positive ID/AST panels",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC of most Gram-negative aerobic and facultative anaerobic bacteria and most Gram-positive bacteria isolates from pure culture, with addition of tobramycin to Gram Positive ID/AST or AST only Phoenix panels",
    "fda_folder": "Microbiology"
}